Moxifloxacin
- Molecular formula
- C21H24FN3O4
- CAS Number
- 151096-09-2
- IUPAC Name
- 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid
- Molecular Weight
- 401.43g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.6000g/cm3
- Appearance
- can vary slightly depending on the manufacture process and form (e.g., anhydrous, monohydrate).
- Synonyms
- Gatifloxacin
Identification
Interesting Facts about 1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid
This compound is an intriguing member of the quinoline family, which is noted for its significant pharmacological activities. Quinoline derivatives, including this one, are hailed for their roles in medicinal chemistry, particularly as:
- Antimicrobial agents: Many compounds in this class exhibit potent antibacterial and antifungal effects.
- Antiviral properties: They are being explored for their effectiveness against various viruses.
- Anticancer potential: Several quinoline derivatives have shown promise in targeting cancer cells.
What makes 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid particularly interesting is its unique molecular structure, which contributes to its biological activity. The presence of the cyclopropyl and piperazine moieties enhances solubility and bioavailability, essential traits for drug development. Scientists are particularly excited about the following aspects:
- Fluorine substitution: The incorporation of a fluorine atom can significantly alter the chemical properties and enhance the binding affinity to biological targets.
- Multi-functional nature: Its structure allows for interactions with multiple biological pathways, making it a versatile lead compound for drug design.
Furthermore, compounds like this one are often subject to extensive research for their role in treating various diseases. The compelling interplay of its constituents showcases the exciting possibilities in synthetic chemistry and drug discovery where structure-activity relationships play a critical role.
In summary, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid exemplifies the innovation in modern medicinal chemistry and the continuous exploration of quinoline derivatives for therapeutic applications.